Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study-Reference-Cited by-同舟云学术

Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study

Published:2020-09-10 Issue:12 Volume:22 Page:2384-2397
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Montvida Olga¹,Verma Subodh²,Shaw Jonathan E.³,Paul Sanjoy K.¹^ORCID

Affiliation:

1. Melbourne EpiCentre University of Melbourne and Melbourne Health Melbourne Victoria Australia

2. Division of Cardiac Surgery University of Toronto, St. Michaelʼ Hospital Toronto Canada

3. Baker IDI Melbourne Victoria Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14164

Reference43 articles.

1. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

2. Why are there ethnic differences in cardio-metabolic risk factors and cardiovascular diseases?

3. Cardiovascular Risk Factor Burden in People With Incident Type 2 Diabetes in the U.S. Receiving Antidiabetic and Cardioprotective Therapies

4. Trends in Racial/Ethnic Disparities in Cardiovascular Health Among US Adults From 1999–2012

5. Racial and Ethnic Differences in Trajectories of Hospitalization in US Men and Women With Heart Failure

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis;Frontiers in Pharmacology;2024-05-23

2. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

3. Racial disparity in the co-occurrence of depression and type 2 diabetes mellitus. An electronic medical record study involving African American and White Caucasian adults from the US;Journal of Affective Disorders;2023-06

4. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

5. Cardiometabolic risk factors and cardiovascular disease predictions in older African and European Americans;Preventive Medicine Reports;2022-12